Biodefense
Programmable Biology Puts Biotech on the Geopolitical Agenda
Synthetic biology is driving a manufacturing revolution, and policymakers are taking note.
Latest in Biodefense
Synthetic biology is driving a manufacturing revolution, and policymakers are taking note.
America’s drug industry is poised to face the same manufacturing crisis the semiconductor industry faces today: a supply chain mired with chokepoints in East Asia that pose direct risks to U.S. national security and economic growth.
Congress can strengthen the Department of Homeland Security’s ability to manage its biodefense responsibilities by taking action now.
Israel reinstated contact-tracing activities by the Israel Security Agency to track carriers of the omicron variant of the coronavirus. Five days later, it halted the ISA’s contact-tracing activities, due to a lack of parliamentary support.
A proposed coronavirus commission could provide a fuller picture of the government’s response to the pandemic. But its success depends on how it is staffed.
India, now the global epicenter of the coronavirus pandemic, is wrestling with what is likely its greatest crisis since Partition. This post walks through the various factors that led the world’s largest democracy from confidence to chaos.
The United States’s track record in responding to the coronavirus pandemic has been awful. Yet the success of its vaccine development efforts shows that when it comes to biotechnology, the U.S. outpaces China and other rivals.
Far fewer coronavirus-related lawsuits have been filed against China in the past few months than previously, an ebb that may reflect any one of several good reasons why would-be plaintiffs would want to wait before bringing a case.
In an effort to combat the spread of the coronavirus, the Biden administration has articulated policy directives supporting protective measures such as mask wearing, social distancing and other science-based public health responses. Here, we are compiling selected executive actions taken by President Biden to respond to the coronavirus pandemic.
Many have discussed the shortcomings of contract-tracing apps during the pandemic. The real problem is the lack of adequate social and public health infrastructure in the U.S.